TrialInternational journal of antimicrobial agents2021

Hydroxychloroquine plus azithromycin early treatment of mild COVID-19 in an outpatient setting: a randomized, double-blinded, placebo-controlled clinical trial evaluating viral clearance.

Cristhieni Rodrigues et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.